Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.

Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:39:22.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to a Phase 1B clinical trial evaluating ASLAN004 versus placebo in patients with moderate-severe Atopic Dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:43:36.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying the inclusion and exclusion criteria for adult patients with chronic atopic dermatitis. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    38%
    Check dated 2024-05-22T21:38:34.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:36:33.000Z thumbnail image

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.